BioNTech co-founders Professor Ozlem Tureci and Dr. Ugur Sahin, predicts that a cancer vaccine could be widely available for patients “before 2030”.
Biotechnology company BioNTech partnered with Pfizer to develop the messenger-RNA (mRNA) shot against COVID-19.
Based on breakthroughs achieved, the cancer vaccine is being trained to recognize and attack cancers using mRNA technology.
“The goal that we have is that can we use the individualized vaccine approach to ensure that directly after surgery, patients receive a personalized, individualized vaccine, and we induce an immune response that so the T-cells in the body of the patient can screen the body for remaining tumor cells and ideally eliminate the tumor cells.”
– Professor Ugur Sahin, Co-Founder of BioNTech
